Thursday, November 21, 2013
Print Current Session:
|
|
Thursday
SESSION 43:
NEW OR IMPROVED TECHNOLOGIES FOR VASCULAR TREATMENT
Moderators:Anton N. Sidawy, MD, MPH / Dhiraj M. Shah, MD
|
|
SESSION 43 SCHEDULE | |
6:55 AM - 7:00 AM | Advantages Of A Fully Self-Expanding Bioabsorbable Stent Scaffold In The Treatment Of SFA Disease: Results Of The STANCE Study |
Presenter(s):Andrew Holden, MBChB | |
7:01 AM - 7:06 AM | Results With The Next Generation Dual Component (Nitinol And PTFE) Stent (Tigris Stent From Gore): Concept And Early Results |
Presenter(s):Konstantinos Katsanos, MSc, MD, PhD, EBIR | |
7:07 AM - 7:12 AM | Diagnosis Of Flow-Limiting Stenosis And Plaque Vulnerability In One Non-Invasive Test: It Will Be Possible And Clinically Useful For Evaluating Peripheral Arterial Stenoses |
Presenter(s):Christopher K. Zarins, MD | |
7:13 AM - 7:18 AM | Update On Biodegradable Stents In The Coronary Position And Elsewhere: Impact Of Fractures On Thrombosis And Restenosis: Why They May Be Important |
Presenter(s):Ron Waksman, MD | |
7:19 AM - 7:24 AM | System For Reducing Radiation Exposure While Maintaining Image Quality During Interventional Procedures |
Presenter(s):Olivier H.J. Koning, MD, PhD | |
7:25 AM - 7:30 AM | What’s New In Drug Eluting Stent (DES) Technology And What Difference Will It Make |
Presenter(s):Ron Waksman, MD | |
7:31 AM - 7:36 AM | Reentry Jugular Access Device |
Presenter(s):Mark H. Wholey, MD / Kumar Pilai, MD | |
7:37 AM - 7:43 AM | Panel Discussion |
END OF SESSION 43 | |
previous | next |